Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Beta-hydroxybutyric Acid-p-phenetidide
2. N-(beta-hydroxybutyryl)-p-phenetidine
3. Nhb-ppt
1. 1083-57-4
2. 3-hydroxy-p-butyrophenetidine
3. Betadid
4. N-(4-ethoxyphenyl)-3-hydroxybutanamide
5. 3-hydroxy-p-butyrophenetidide
6. Butanamide, N-(4-ethoxyphenyl)-3-hydroxy-
7. 3-hydroxy-4-butyrophenetidide
8. Bucetinum
9. 4'-ethoxy-3-hydroxybutyranilide
10. P-butyrophenetidide, 3-hydroxy-
11. (+)-bucetin
12. (-)-bucetin
13. Bucetin, (+)-
14. Bucetin, (-)-
15. Butyranilide, 4'-ethoxy-3-hydroxy-
16. Nsc-320045
17. Nsc-759243
18. 6m7cvq8pf8
19. Plf54f8s2f
20. 1z23wb033i
21. Butanamide, N-(4-ethoxyphenyl)-3-hydroxy-, (+)-
22. Butanamide, N-(4-ethoxyphenyl)-3-hydroxy-, (-)-
23. .beta.-hydroxybutyric Acid P-phenetidide
24. Ncgc00166139-01
25. Dsstox_cid_721
26. Dsstox_rid_75756
27. Dsstox_gsid_20721
28. 156674-10-1
29. 156674-11-2
30. Bucetina
31. Bucetine
32. Bucetine [inn-french]
33. Bucetinum [inn-latin]
34. Bucetina [inn-spanish]
35. Bucetin [inn:ban:jan]
36. Cas-1083-57-4
37. Ccris 2654
38. Hoe 15239
39. (+/-)-bucetin
40. Einecs 214-109-8
41. Beta-hydroxybutyric Acid-p-phenetidide
42. Unii-6m7cvq8pf8
43. Unii-plf54f8s2f
44. Brn 2725755
45. Beta-oxybuttersaeure-p-phenetidid [german]
46. Unii-1z23wb033i
47. Beta-oxybuttersaeure-p-phenetidid
48. Bucetin (jan/inn)
49. Bucetin [inn]
50. Bucetin [jan]
51. Bucetin [mi]
52. N-[4-(ethyloxy)phenyl]-3-hydroxybutanamide
53. Bucetin [who-dd]
54. Bucetin, Analytical Standard
55. 3-hydroxy-p-butyrophenetidid
56. Schembl25373
57. 4-13-00-01216 (beilstein Handbook Reference)
58. Mls004773907
59. Chembl1697856
60. Dtxsid6020721
61. Chebi:31311
62. Liawqaskbfcrnr-uhfffaoysa-
63. Hms3264h19
64. Pharmakon1600-01505772
65. .beta.-oxybuttersaeure-p-phenetidid
66. Bcp10106
67. Hy-b0906
68. N-(3-hydroxybutyryl)-p-phenetidine
69. Tox21_112334
70. Tox21_201816
71. Tox21_302889
72. Mfcd00021906
73. Nsc320045
74. Nsc759243
75. S4554
76. Akos024319288
77. Tox21_112334_1
78. Ccg-214013
79. Db13278
80. Nsc 320045
81. Nsc 759243
82. .beta.-hydroxybutyric Acid-p-phenetidide
83. Ncgc00166139-02
84. Ncgc00166139-03
85. Ncgc00256519-01
86. Ncgc00259365-01
87. Bs-14398
88. Smr001550502
89. N-(4-ethoxyphenyl)-3-hydroxybutanamide #
90. P-ethoxy-n-(.beta.-hydroxybutyryl)aniline
91. Sbi-0207039.p001
92. H0371
93. C71309
94. D01116
95. Ab01563248_01
96. A852163
97. Sr-01000872775
98. J-002129
99. Q4982520
100. Sr-01000872775-1
| Molecular Weight | 223.27 g/mol |
|---|---|
| Molecular Formula | C12H17NO3 |
| XLogP3 | 1.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 5 |
| Exact Mass | 223.12084340 g/mol |
| Monoisotopic Mass | 223.12084340 g/mol |
| Topological Polar Surface Area | 58.6 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 212 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
N - Nervous system
N02 - Analgesics
N02B - Other analgesics and antipyretics
N02BE - Anilides
N02BE04 - Bucetin
ABOUT THIS PAGE
64
PharmaCompass offers a list of Bucetin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bucetin manufacturer or Bucetin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bucetin manufacturer or Bucetin supplier.
PharmaCompass also assists you with knowing the Bucetin API Price utilized in the formulation of products. Bucetin API Price is not always fixed or binding as the Bucetin Price is obtained through a variety of data sources. The Bucetin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bucetin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bucetin, including repackagers and relabelers. The FDA regulates Bucetin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bucetin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bucetin supplier is an individual or a company that provides Bucetin active pharmaceutical ingredient (API) or Bucetin finished formulations upon request. The Bucetin suppliers may include Bucetin API manufacturers, exporters, distributors and traders.
Bucetin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bucetin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bucetin GMP manufacturer or Bucetin GMP API supplier for your needs.
A Bucetin CoA (Certificate of Analysis) is a formal document that attests to Bucetin's compliance with Bucetin specifications and serves as a tool for batch-level quality control.
Bucetin CoA mostly includes findings from lab analyses of a specific batch. For each Bucetin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bucetin may be tested according to a variety of international standards, such as European Pharmacopoeia (Bucetin EP), Bucetin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bucetin USP).
